Results 151 to 160 of about 60,638 (316)
Diabetes, Obesity and Metabolism, EarlyView.Abstract Insulin has been discovered for more than a century; however, its benefits to people with diabetes are yet to be fully realized due to barriers related to access, quality of care and costs. Insulin therapy remains the cornerstone of diabetes management. The multicausality of diabetes and its subtypes calls for comprehensive phenotyping and use
Aimin Yang +4 more
wiley +1 more source
Evaluation of hyperglycaemic emergency admissions to a major tertiary centre over a two‐year period
Diabetic Medicine, EarlyView.
Serena Chong +3 more
wiley +1 more source
Type 1 diabetes presenting in adults: Trends, diagnostic challenges and unique features
Diabetes, Obesity and Metabolism, EarlyView.Abstract Type 1 diabetes (T1D) has been historically regarded as a childhood‐onset disease; however, recent epidemiological data indicate that adult‐onset T1D accounts for a substantial proportion of cases worldwide. There is evidence that adult‐onset T1D is associated with the classic T1D triad of elevated genetic risk, the presence of islet‐specific ...
Carmella Evans‐Molina, Richard A. Oram
wiley +1 more source
Diabetic Ketoacidosis in Children - An Experience in a Tertiary Hospital
, 1970 Bedowra Zabeen +4 more
openalex +2 more sources
Heterogeneity in the management of diabetic ketoacidosis in Australia: a national survey
Internal Medicine Journal, EarlyView.Abstract Background Diabetic ketoacidosis (DKA) is a hyperglycaemic emergency, and insulin administration is highly protocolised with either variable‐ or fixed‐rate intravenous infusions. There are limited data supporting superiority of one regimen over another; however, international guidelines recommend fixed‐rate infusions.
Lisa M. Raven +6 more
wiley +1 more source
Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
Безопасность и риск фармакотерапии, 2018 SGLT2 inhibitors form a new class of hypoglycemic drugs. Despite of the pharmacodynamic profile, at the moment the opinion about their safety is controversial. This is due to increased number of reports given by FDA and EMA on the risk of serious adverse
T. M. Bukatina +6 more
doaj
Diabetes, Metabolic Syndrome and Obesity, 2020 Meichen Qian,1 Na Wu,1,2 Ling Li,1 Wenshu Yu,1 Hong Ouyang,1 Xinyan Liu,1 Yujing He,1 Abdulrahman Al-Mureish2 1Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang 110004, People’s Republic of China; 2Clinical ...
Qian M +7 more
doaj
Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. [PDF]
, 1984 P J Hale, J. Crase, M. Nattrass
openalex +1 more source
The ‘nephrotoxins’ were stopped: what is in a name and its impact on kidney and cardiac health?
Internal Medicine Journal, EarlyView.Abstract The term ‘nephrotoxin’ is often imprecisely applied to medications that are not inherently toxic to the kidneys, including renin‐angiotensin‐aldosterone system inhibitors, sodium‐glucose co‐transporter 2 inhibitors, diuretics and metformin. These drugs are frequently included in ‘sick day rules’ and may be prematurely discontinued during acute
Catherine Mao, Bobby Chacko
wiley +1 more source